Iterum Therapeutics Provides Business Update
Provided By GlobeNewswire
Last update: Sep 19, 2025
DUBLIN and CHICAGO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today provided a general business update.
Read more at globenewswire.com
